DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)

Clinical trial NCT00302341 · TERMINATED

Trial details

NCT number: NCT00302341
Sponsor: Immtech Pharmaceuticals, Inc
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumonia, Interstitial Plasma Cell Pneumocystis Carinii Pneumonia Pneumonia, Pneumocystis Carinii HIV Infections

Start date: 2006-05-01
Primary completion: 2008-12-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.